Medicare Payment Cuts Put Value-Based Care on a Failing Financial Footing
Medicare’s final 2027 physician fee schedule does more than trim reimbursement. It deepens a structural problem that has kept many physicians from entering value-based care in the first place: the margin to absorb risk keeps shrinking while the downside exposure keeps growing.
The final schedule lowers the conversion factor by 2.31% for most physicians and by 1.83% for those in qualifying advanced alternative payment models. In practical terms, the policy reaches the very groups Medicare says it wants to expand, yet it does so by reducing the payment buffer that makes participation possible. Aisha T. Pittman, senior vice president of government affairs at the National Association of ACOs, argues that physicians need adequate payment before they can accept the financial risk built into an accountable care organization. Congress, in her view, needs to reverse the cut.
A physician can tolerate clinical uncertainty. A practice cannot tolerate a reimbursement model that narrows every quarter while fixed costs keep climbing.
Why ACO Participation Breaks Down at the Margins
Accountable care organizations ask physicians to manage populations more tightly, coordinate across settings, reduce avoidable utilization, and accept financial accountability if total spending runs too high. In theory, that structure rewards prevention, continuity, and smarter resource use. In real practice, it requires upfront investment in staff, analytics, care coordination, and patient outreach long before shared savings arrive. If the base fee schedule is falling at the same time, the operating margin available to support those investments thins out fast.
That financial squeeze is not a side issue. It changes behavior at the point where physicians decide whether a new contract is worth the administrative burden and downside risk. A lower conversion factor means less revenue attached to the same work, which makes it harder to hire care managers, purchase data infrastructure, or absorb months of delay before a performance payment comes through. For smaller groups in particular, the fee cut can turn participation in advanced models from a strategic choice into a balance-sheet hazard.
Pittman’s argument rests on a basic economic fact: value-based care only scales when the underlying payment system can support the transition period. Without that support, physicians may stay in fee-for-service arrangements that are easier to predict, even if those models do less to reward prevention or coordination.
The Advanced APM Cut Sends the Wrong Signal
The 1.83% cut for qualifying advanced alternative payment models is especially consequential because it lands on the very physicians Medicare expects to lead the shift away from volume-based billing. These clinicians have already taken on some level of quality reporting, risk-bearing, or performance accountability. Reducing their payment rate sends a blunt signal that the system is asking for more transformation while offering less protection against revenue erosion.
That dynamic matters because advanced APM participation is not costless. It usually demands more robust care management, tighter attribution methods, and a more disciplined approach to utilization. Every one of those steps carries labor and technology costs. When the conversion factor declines, those costs become harder to justify unless shared savings are large, reliable, and close enough to offset the immediate hit to cash flow. For many physician groups, that is not a theoretical spreadsheet problem. It is the difference between expanding a care coordination team and freezing hiring.
Congress, Medicare, and the Business Case for Risk
Pittman wants Congress to reverse the cut, and the reason is straightforward. If policymakers want physicians to take on downside risk, then payment policy has to preserve enough stability to make that risk survivable. The current schedule works in the opposite direction: it compresses revenue while expecting broader participation in models that depend on operational flexibility.
That contradiction helps explain why adoption of value-based care can stall even when the policy rhetoric is strong. Physicians do not enter an ACO because the concept is appealing on paper. They enter when the numbers allow them to invest in population health tools, endure initial losses, and still keep the practice solvent. Medicare payment cuts undermine all three conditions at once.
Shared savings models also depend on trust. Providers need confidence that the rules will not shift so sharply that a long-term contract becomes a short-term gamble. Repeated fee reductions erode that confidence. Once that happens, practices become more cautious about joining arrangements that expose them to repayments or performance penalties if benchmarks are missed.
Bedside Consequences Reach Beyond the Billing Office
These policy choices do not stay confined to finance departments. When margins shrink, the first thing sacrificed is often the infrastructure that makes population medicine work: care coordinators, follow-up calls, medication reconciliation, and outreach to patients with missed visits or rising risk. Those services are expensive because they are labor-intensive, but they are also the mechanisms that reduce avoidable admissions and emergency department use.
The Medicare fee schedule therefore affects more than physician revenue. It shapes whether practices can build the support systems that allow chronic disease management to function outside a fee-for-service rhythm. A lower payment floor makes it harder to keep those systems intact, especially in practices that already operate on narrow margins. The result is a slower transition to value-based care, even in systems that publicly endorse it.
For many physicians, the question is not whether value-based care is worth pursuing. It is whether the payment structure can absorb the cost of getting there.
What the 2027 Schedule Reveals About Policy Priorities
The 2027 fee schedule exposes a familiar mismatch in Medicare policy. On one hand, Medicare continues to promote alternative payment models and accountable care. On the other, it still relies on fee updates that can undercut the very groups expected to lead that transition. A cut of 2.31% for most physicians and 1.83% for qualifying advanced APM participants may appear modest in isolation, but in aggregate it reinforces the same financial pressure that has slowed broader migration into value-based care.
The policy question is not simply whether physicians can adapt. Many already have. The deeper issue is whether federal payment updates create enough room for practices to participate without taking on unsustainable risk. If the answer remains no, then the pipeline into accountable care stays narrower than policymakers intend.
Congress now sits at the center of that decision. Reversing the cut would not solve every structural flaw in physician payment, but it would remove one immediate barrier to ACO participation and send a clearer signal that Medicare intends to make risk-based care financially viable rather than merely aspirational.